Mantzaris GJ, Bressler B, Adsul S, Luo M, et al. Effectiveness and safety of vedolizumab and infliximab in biologic-naive patients with Crohn's disease: results from the EVOLVE study. Eur J Gastroenterol Hepatol 2023 Dec 27. doi: 10.1097/MEG.0000000000002690.
PMID: 38179874